KRAS signaling in malignant pleural mesothelioma-Reference-Cited by-同舟云学术

KRAS signaling in malignant pleural mesothelioma

Published:2021-12-13 Issue:2 Volume:14 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Marazioti Antonia¹²,Krontira Anthi C²,Behrend Sabine J¹³^ORCID,Giotopoulou Georgia A¹²³^ORCID,Ntaliarda Giannoula²^ORCID,Blanquart Christophe⁴,Bayram Hasan⁵⁶^ORCID,Iliopoulou Marianthi²,Vreka Malamati¹²³,Trassl Lilith¹³,Pepe Mario A A¹³,Hackl Caroline M¹³,Klotz Laura V¹³,Weiss Stefanie A I¹³^ORCID,Koch Ina³⁷,Lindner Michael³⁷,Hatz Rudolph A³⁷,Behr Juergen³⁸,Wagner Darcy E¹³⁹^ORCID,Papadaki Helen¹⁰,Antimisiaris Sophia G¹¹¹²,Jean Didier¹³^ORCID,Deshayes Sophie⁴,Grégoire Marc⁴,Kayalar Özgecan⁶^ORCID,Mortazavi Deniz⁶,Dilege Şükrü¹⁴,Tanju Serhan¹⁴^ORCID,Erus Suat¹⁴^ORCID,Yavuz Ömer¹⁴^ORCID,Bulutay Pınar¹⁵,Fırat Pınar¹⁵,Psallidas Ioannis²,Spella Magda²^ORCID,Giopanou Ioanna²,Lilis Ioannis²^ORCID,Lamort Anne‐Sophie¹³^ORCID,Stathopoulos Georgios T¹²³^ORCID

Affiliation:

1. Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD) Helmholtz Center Munich‐German Research Center for Environmental Health (HMGU) and Ludwig‐Maximilian‐University (LMU) Munich Munich Germany

2. Laboratory for Molecular Respiratory Carcinogenesis Department of Physiology Faculty of Medicine University of Patras Rio Greece

3. German Center for Lung Research (DZL) Gießen Germany

4. Université de Nantes CNRS INSERM CRCINA Nantes France

5. Department of Pulmonary Medicine Koc University School of Medicine Istanbul Turkey

6. Koc University Research Center for Translational Medicine (KUTTAM) Koc University School of Medicine Istanbul Turkey

7. Center for Thoracic Surgery Munich Ludwig‐Maximilian‐University (LMU) Munich and Asklepios Medical Center Gauting Germany

8. Department of Medicine V University Hospital Ludwig‐Maximilian‐University (LMU) Munich Munich Germany

9. Lung Bioengineering and Regeneration Department of Experimental Medical Sciences Lund Stem Cell Center Wallenberg Molecular Medicine Center Faculty of Medicine Lund University Lund Sweden

10. Department of Anatomy Faculty of Medicine University of Patras Rio Greece

11. Laboratory for Pharmaceutical Technology Department of Pharmacy School of Health Sciences University of Patras Rio Greece

12. Foundation for Research and Technology Hellas Institute of Chemical Engineering FORTH/ICE‐HT Rio Greece

13. Centre de Recherche des Cordeliers INSERM Sorbonne Université Université de Paris Functional Genomics of Solid Tumors Paris France

14. Department of Thoracic Surgery Koc University School of Medicine Istanbul Turkey

15. Department of Pathology Koc University School of Medicine Istanbul Turkey

Funder

European Respiratory Society

Institut National de la Santé et de la Recherche Médicale

Deutsche Forschungsgemeinschaft

Bundesministerium für Bildung und Forschung

FP7 Ideas: European Research Council

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202013631

Reference104 articles.

1. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

2. Mutant KRAS promotes malignant pleural effusion formation

3. Tumor Suppressor p53 Is Required To Modulate BRCA1 Expression

4. Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma

5. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity;npj Precision Oncology;2024-06-15

2. Characterization of KLHL14 anti-oncogenic action in malignant mesothelioma;Heliyon;2024-03

3. Introduction to liposome assisted drug delivery;Liposomes in Drug Delivery;2024

4. Clinical Next Generation Sequencing Application in Mesothelioma: Finding a Golden Needle in the Haystack;Cancers;2023-12-06

5. Important functional role of the protein osteopontin in the progression of malignant pleural mesothelioma;Frontiers in Immunology;2023-06-16